Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/1998
10/06/1998US5817511 Nucleotide sequence coding for variable regions of the α chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
10/06/1998US5817303 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
10/01/1998WO1998042751A1 Oxidised fragments of apolipoprotein b and their use
10/01/1998WO1998042734A1 Process of purification of cyclosporin
10/01/1998WO1998042733A1 uPAR MIMICKING PEPTIDE
10/01/1998WO1998042365A1 Ligand/lytic peptide compositions and methods of use
10/01/1998WO1998042364A1 Ligand/lytic peptide compositions and methods of use
09/1998
09/30/1998EP0867450A1 Novel peptide
09/30/1998EP0866878A1 Detection of mammary tumor virus-like sequences in human breast cancer
09/30/1998EP0866864A2 Antifungal proteins
09/30/1998EP0866851A1 Tumour vaccine and process for the preparation thereof
09/30/1998EP0866801A1 Cyclopeptolides
09/30/1998EP0866800A2 Antineoplastic peptides
09/30/1998EP0551460B1 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV)
09/30/1998CN1194667A Manipulation and detection of protein phosphatase 2C-PP2C alpha-expression in tumor cell for cancer therapy, prevention and detection
09/29/1998US5814610 Tetrapeptides to hexapeptides with specific amino acid sequences for wound healing agents and osteoblast or fibroblastic growth promoters
09/29/1998US5814604 A pair of polypeptide chains disulfide bonded to form a dimeric species
09/29/1998US5814507 κ/μ-like protein tyrosine phosphatase, PTP λ
09/29/1998US5814459 Phosphospecific transcription factor antibodies
09/29/1998US5814456 Sperm antigen corresponding to a sperm zone binding protein autoantigenic epitope
09/29/1998US5814441 HTLV-I and HTLV-II peptide antigens and methods
09/29/1998US5814317 Structural alterations of the EGF receptor gene in human gliomas
09/29/1998US5814298 Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
09/29/1998US5814297 Amino acid residues covalently linked to a radioisotope
09/24/1998WO1998041542A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
09/24/1998WO1998041535A2 Activation of peptides
09/24/1998WO1998041224A1 Use of protegrins for periodontal indications
09/24/1998WO1998041223A1 N-methyl-d-aspartate receptor channel blockers and method for identifying such
09/23/1998EP0866075A2 Method to treat microbial infections by uncoupling of phosphotransferase system and appropriate agents therefor
09/23/1998EP0865491A1 Compounds having lectin properties and biological uses thereof
09/23/1998EP0865447A1 Cyclic dodecapeptide and process for the preparation thereof
09/23/1998EP0865446A1 Agents for promoting bone formation
09/23/1998EP0865292A1 Compositions and methods for the prevention and treatment of oral mucositis
09/23/1998EP0678100B1 Synthetic amphipathic peptides with antimicrobial activity
09/23/1998CN1193997A Methodology to produce, purify and assay polypeptides with proteolytic activity of HCV NS3 protease
09/23/1998CN1193889A Peptides derived from human heat shock protein 60 for treatment of diabetes, compositions methods and kits
09/22/1998US5811548 Tri-and tetracyclic compounds
09/22/1998US5811515 Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis
09/22/1998US5811399 Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
09/22/1998US5811394 Technetium-99m labeled polypeptides for imaging
09/22/1998US5811392 Conformationally constrained backbone cyclized peptide analogs
09/22/1998US5811389 Inhibiting platelet aggregation; blood disorders
09/22/1998US5811387 Enzyme resistant oligo- or poly-peptoid which may selectively bind to polypeptide or effector molecule; mimetics, peptoid libraries
09/22/1998US5811106 Polypeptides produced by human malaria parasites
09/22/1998CA2056911C Hiv protease inhibitors
09/17/1998WO1998040738A1 Prostate specific antigen substrates
09/17/1998WO1998040502A1 Peptide-enhanced transfections
09/17/1998WO1998040403A1 Psca: prostate stem cell antigen
09/17/1998WO1998040401A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
09/17/1998WO1998040400A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus
09/17/1998WO1998040093A1 Method of antagonizing the human src sh2 domain
09/17/1998WO1998040092A1 Dolastatin-15 derivatives in combination with taxanes
09/17/1998WO1998033813A3 Method for accelerating healing of thermal injuries
09/17/1998CA2727634A1 Calcium fluoride phosphate complexes
09/17/1998CA2297164A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus
09/17/1998CA2284137A1 Prostate specific antigen substrates
09/17/1998CA2283472A1 Method of antagonizing the human src sh2 domain
09/17/1998CA2282807A1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
09/16/1998EP0864584A1 Lipopetide from Actinoplanes sp. with pharmacological properties, process for its preparation and its use
09/16/1998EP0863917A1 Targeted cytotoxic anthracycline analogs
09/16/1998EP0765341A4 Template directed cyclization
09/16/1998EP0666920B1 Thrombin activatable plasminogen derivatives
09/16/1998EP0644897B1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors
09/16/1998CN1193352A Human chitinase, its recombinant production, its use for decomposing chitin, and its use in therapy or prophylaxis against infection diseases
09/16/1998CN1193349A Vaccine for infectious agents, compositions for treating and preventing HIV infections
09/16/1998CN1193325A Cell adhension inhibitors
09/15/1998US5808029 Genetic engineering
09/15/1998US5807986 Genetic engineering
09/15/1998US5807985 Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
09/15/1998US5807984 Controlling diseases; pentapeptides
09/15/1998US5807983 Human gonadotropin releasing hormone
09/15/1998US5807982 Affinity purified heparin
09/15/1998US5807979 Genetic engineering; hybrids polypeptides
09/15/1998US5807830 Method for treatment of purulent inflammatory diseases
09/15/1998US5807826 Semaphorin gene family
09/15/1998US5807819 Using an oligopeptide
09/15/1998US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products
09/15/1998US5807548 Method of treating cancer using a chimera antibody
09/15/1998US5807537 Medical diagnosis
09/11/1998WO1998039469A1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
09/11/1998WO1998031704A3 Tachykinin antagonists
09/11/1998WO1998027110A3 Dihydroxypropyl cysteine peptide and agent containing this peptide
09/11/1998CA2283474A1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
09/11/1998CA2282827A1 Method of alleviating neuropathic pain
09/09/1998EP0863156A1 Peptides useful as somatostatin antagonists
09/09/1998EP0863155A1 Suppression of T-cell proliferation using peptide fragments of myelin basic protein
09/09/1998EP0863139A1 Benzoxazindione derivatives, process for their preparation and their use
09/09/1998EP0862579A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
09/09/1998EP0862578A1 Actinomycin d analogues
09/09/1998EP0862448A1 Fine tuned protegrins
09/09/1998EP0650498B1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
09/09/1998CN1192750A Cyclosporin derivatives with anti-HIV effect
09/09/1998CN1192749A Peptide and compounds that bind to receptor
09/09/1998CN1192748A Compounds and peptide that bind to the erythropoietin receptor
09/09/1998CN1192733A Stable reagent for prepn. of radiopharmaceuticals
09/09/1998CN1192689A Appetite regulating compositions
09/08/1998US5804563 Synthetic receptors, libraries and uses thereof
09/08/1998US5804559 Prodrug derivatives of enzyme inhibitors having hydroxyl groups, a process for preparing them, and their use
09/08/1998US5804558 Containing disulfide bonds; useful as preservatives and in preventing, treating or ameliorating viral or microbial infections in animals and plants
09/08/1998US5804552 Compound consisting of tyrosine or hydroxyproline linked to phospholipid by phosphoester bond through hydroxyl group; capable of conjugation with therapeutic peptide